SIRT1 regulates oncogenesis via a mutant p53-dependent pathway in hepatocellular carcinoma

Journal of Hepatology

Volumn 62, Issue 1, 2016, Pages 121-130

  Zhang, Zheng Yun ^a,b   Hong, Doopyo ^b   Nam, Seung Hoon ^b   Kim, Jong Man ^b   Paik, Yong Han ^b   Joh, Jae Won ^b   Kwon, Choon Hyuck David ^b   Park, Jae Berm ^b   Choi, Gyu Seong ^b   Jang, Kyu Yun ^c   Park, Cheol Keun ^b   Kim, Sung Joo ^b  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

^b Samsung Medical Center   (South Korea)

^c Chonbuk National University Medical School   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE KINASE; MAMMALIAN TARGET OF RAPAMYCIN; METFORMIN; PROTEIN P53; SERINE; SIRTUIN 1; THREONINE; DNA; SIRT1 PROTEIN, HUMAN;

ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER PROGNOSIS; CANCER SURVIVAL; CANCER TISSUE; CELL GROWTH; CELL MUTANT; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; ENZYME INHIBITION; GENE; GENE INACTIVATION; GENE MUTATION; GROWTH INHIBITION; HUMAN; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; OVERALL SURVIVAL; P53 GENE; PREDICTION; PROTEIN EXPRESSION; RECURRENCE FREE SURVIVAL; APOPTOSIS; BIOSYNTHESIS; CARCINOGENESIS; DNA MUTATIONAL ANALYSIS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; LIVER TUMOR; MALE; METABOLISM; MIDDLE AGED; MUTATION; PATHOLOGY; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; TUMOR CELL CULTURE; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CARCINOGENESIS; CARCINOMA, HEPATOCELLULAR; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; SIRTUIN 1; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84918834477     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2014.08.007     Document Type: Article

References (28)

1. D.M. Parkin Global cancer statistics in the year 2000 Lancet Oncol 2 2001 533 543
2. J. Luo, A.Y. Nikolaev, S. Imai, D. Chen, F. Su, and A. Shiloh Negative control of P53 by Sir2alpha promotes cell survival under stress Cell 107 2001 137 148
3. H. Vaziri, S.K. Dessain, E.N. Eaton, S.I. Imai, R.A. Frye, and T.K. Pandita hSIR2 (SIRT1) functions as an NAD-dependent P53 deacetylase Cell 107 2001 149 159
4. W.Y. Chen, D.H. Wang, R.C. Yen, J. Luo, W. Gu, and S.B. Baylin Tumour suppressor HIC1 directly regulates SIRT1 to modulate P53-dependent DNA-damage responses Cell 123 2005 437 448
5. S.B. Baylin, and J.E. Ohm Epigenetic gene silencing in cancer-A mechanism for early oncogenic pathway addiction? Nat Rev Cancer 6 2006 107 116
6. C.S. Lim Human SIRT1: a potential biomarker for tumorigenesis? Cell Biol Int 31 2007 636 637
7. L.R. Saunders, and E. Verdin Sirtuins: critical regulators at the crossroads between cancer and aging Oncogene 26 2007 5489 5504
8. E.J. Cha, S.J. Noh, K.S. Kwon, C.Y. Kim, B.H. Park, and H.S. Park Expression and prognostic significance of SIRT1 in ovarian epithelial tumors Pathology 41 2009 366 371
9. H. Lee, K.R. Kim, S.J. Noh, H.S. Park, K.S. Kwon, and B.H. Park Expression of DBC1 and SIRT1 is associated with poor prognosis for breast carcinoma Hum Pathol 42 2011 204 213
10. K.Y. Jang, S.H. Hwang, K.S. Kwon, K.R. Kim, H.N. Choi, and N.R. Lee SIRT1 expression is associated with poor prognosis of diffuse large B-cell lymphoma Am J Surg Pathol 32 2008 1523 1531
11. J. Chen, B. Zhang, N. Wong, A.W. Lo, K.F. To, and A.W. Chan Sirtuin 1 is upregulated in a subset of hepatocellular carcinomas where it is essential for telomere maintenance and tumor cell growth Cancer Res 71 2011 4138 4149
12. H.N. Choi, J.S. Bae, U. Jamiyandorj, S.J. Noh, H.S. Park, and K.Y. Jang Expression and role of SIRT1 in hepatocellular carcinoma Oncol Rep 26 2011 503 510
13. N. Kabra, Z. Li, L. Chen, B. Li, X. Zhang, and C. Wang SIRT1 is an inhibitor of proliferation and tumor formation in colon cancer J Biol Chem 28 2009 18210 18217
14. H.C. Chen, Y.M. Jeng, R.H. Yuan, H.C. Hsu, and Y.L. Chen SIRT1 promotes tumorigenesis and resistance to chemotherapy in hepatocellular carcinoma and its expression predicts poor prognosis Ann Surg Oncol 19 2012 2011 2019
15. J.R. Revollo, A.A. Grimm, and S. Imai The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells J Biol Chem 279 2004 50754 50763
16. V. Nin, C. Escande, C.C. Chini, S. Giri, J. Camacho-Pereira, and J. Matalonga Role of Deleted in Breast Cancer 1 (DBC1) protein in SIRT1 deacetylase activation induced by protein kinase A and AMP-Activated protein kinase J Biol Chem 287 2012 23489 23501
17. J.N. Lin, V.C. Lin, K.M. Rau, P.C. Shieh, D.H. Kuo, and J.C. Shieh Resveratrol modulates tumor cell proliferation and protein translation via SIRT1-dependent AMPK activation J Agric Food Chem 58 2010 1584 1592
18. E. Vakana, J.K. Altman, and L.C. Platanias Targeting AMPK in the treatment of malignancies J Cell Biochem 113 2012 404 409
19. J. Woodard, and L.C. Platanias AMP-Activated kinase (AMPK)-generated signals in malignant melanoma cell growth and survival Biochem Biophys Res Commun 398 2010 135 139
20. A.V. Budanov, and M. Karin P53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling Cell 134 2008 451 460
21. C. Canto, Z. Gerhart-Hines, J.N. Feige, M. Lagouge, L. Noriega, and J.C. Milne AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity Nature 458 2009 1056 1060
22. V.N. Ivanov, M.A. Partridge, G.E. Johnson, S.X. Huang, H. Zhou, and T.K. Hei Resveratrol sensitizes melanomas to TRAIL through modulation of antiapoptotic gene expression Exp Cell Res 314 2008 1163 1176
23. F. Lan, J.M. Cacicedo, N. Ruderman, and Y. Ido SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-Activated protein kinase activation J Biol Chem 283 2008 27628 27635
24. N.L. Price, A.P. Gomes, A.J. Ling, F.V. Duarte, A. Martin-Montalvo, and B.J. North SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function Cell Metab 15 2012 675 690
25. D.M. Gwinn, D.B. Shackelford, D.F. Egan, M.M. Mihaylova, A. Mery, and D.S. Vasquez AMPK phosphorylation of raptor mediates a metabolic checkpoint Mol Cell 30 2008 214 226
26. M.E. Juan, I. Alfaras, and J.M. Planas Colorectal cancer chemoprevention by trans resveratrol Pharmacol Res 65 2012 584 591
27. D. Calay, D. Vind-Kezunovic, A. Frankart, S. Lambert, Y. Poumay, and R. Gniadecki Inhibition of Akt signaling by exclusion from lipid rafts in normal and transformed epidermal keratinocytes J invest Dermatol 130 2010 1136 1145
28. J.H. Back, H.R. Rezvani, Y. Zhu, V. Guyonnet-Duperat, M. Athar, and D. Ratner Cancer cell survival following DNA damage-mediated premature senescence is regulated by mammalian target of rapamycin (mTOR)-dependent Inhibition of sirtuin 1 J Biol Chem 286 2010 19100 19108